New Model for the Pharmaceutical Industry: The Institute for OneWorld Health Harvard Case Solution & Analysis

Institute for OneWorld Health represents (IOWH), company manufacturing medicines for neglected diseases and the first nonprofit pharmaceutical company in the world. Founded in 2000 by Dr. Victoria Hale, IOWH took expired and donated the patent compounds and develop them through all stages of clinical trials and approval of drugs to fight the most devastating diseases in the world, tend to occur in third world countries where the perceived profitable markets do not yet exist. By 2004 IOWH presents its first Phase 3 clinical trial results for Paromomycin, a drug designed for visceral leishmaniasis, which killed as many as 200,000 people each year in India, Bangladesh, Sudan, Brazil, Nepal. His next task was to form partnerships with other organizations in the manufacturing and distribution of drugs. The focus is on strategies for Hale IOWH go ahead with a particular focus on their core competencies and mission. "Hide
by Johanna Mair, Oliver Schoen Source: IESE 33 pages. Publication Date: April 1, 2005. Prod. #: IES109-PDF-ENG

New Model for the Pharmaceutical Industry: The Institute for OneWorld Health Case Solution Other Similar Case Solutions like

New Model for the Pharmaceutical Industry: The Institute for OneWorld Health

Share This